ANTI-TNF-ALPHA/CXCL10 DOUBLE-TARGETING ANTIBODY AND USE THEREOF
The present invention relates to a TNF-± (tumor necrosis factor-alpha)/CXCL-10 (C-X-C motif chemokine 10) double targeting antibody based on the IgG format. Specifically, it was verified that an antibody, in which scFv having a heavy chain variable domain and a light chain variable domain of the CXC...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a TNF-± (tumor necrosis factor-alpha)/CXCL-10 (C-X-C motif chemokine 10) double targeting antibody based on the IgG format. Specifically, it was verified that an antibody, in which scFv having a heavy chain variable domain and a light chain variable domain of the CXCL10 specific antibody links to the C-terminus of the heavy chain constant domain of the TNF-± specific antibody, is a bispecific antibody that effectively binds to both TNF-± and CXCL10, and thus the antibody can be useful as a double targeting antibody capable of identifying TNF-±/CXCL10. A composition of the present invention comprises a TNF-±/CXCL-10 double targeting antibody which effectively binds to both TNF-± and CXCL10. The double targeting antibody of the present invention has excellent TNF-± inhibitory activity and osteoclast differentiation inhibitory activity compared with the TNF-± or CXCL10 single targeting antibody. The composition of the present invention can be used in preventing or treating immunological disease. |
---|